Articles

The efficacy of a bioactive moisturizer in mitigating side effects of acne therapies: a randomized, investigator-blind, split-face trial

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 27 March 2026
300
Views
199
Downloads

Authors

Acne treatments often cause mucocutaneous side effects. This study compared a bioactive moisturizer (containing 4-t-butylcyclohexanol, licochalcone A, ceramide, and panthenol) with a traditional moisturizer in Asian patients using adapalene/benzoyl peroxide gel or oral isotretinoin. Forty participants applied each moisturizer to one side of the face. Assessments at weeks 0, 2, and 4 included hydration, trans-epidermal water loss (TEWL), pH, erythema, acne lesion counts, Investigator Global Evaluation of Acne (IGEA), and patient satisfaction. Hydration increased on both sides, with greater improvement from the bioactive moisturizer (p=0.001). TEWL increased more with the traditional moisturizer; skin pH decreased on both sides. Acne lesions decreased equally. Both moisturizers reduced burning sensations, but dryness scores were higher with the traditional product (p=0.021). Patient satisfaction was significantly higher for the bioactive side (p=0.004). The bioactive moisturizer significantly improves hydration and reduces dryness, supporting its role as an adjunct to acne therapy.

Downloads

Download data is not yet available.

Citations

1. Tan JK, Bhate K. A global perspective on the epidemiology of acne. Brit J Dermatol 2015;172:3-12.
2. Knutsen-Larson S, Dawson AL, Dunnick CA, Dellavalle RP. Acne vulgaris: pathogenesis, treatment, and needs assessment. Dermatol Clin 2012;30:99-106.
3. Dull K, Lénárt K, Dajnoki Z, et al. Barrier function-related genes and proteins have an altered expression in acne-involved skin. J Eur Acad Dermatol 2023;37:1415-25.
4. Hayran Y, Incel Uysal P, Oktem A, et al. Factors affecting adherence and patient satisfaction with treatment: a cross-sectional study of 500 patients with acne vulgaris. J Dermatol Treat 2021;32:64-9.
5. Thiboutot DM, Dréno B, Abanmi A, et al. Practical management of acne for clinicians: an international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2018;78.
6. Chandan N, Rajkumar JR, Shi VY, Lio PA. A new era of moisturizers. J Cosmet Dermatol 2021;20:2425-30.
7. Kueper T, Krohn M, Haustedt LO, et al. Inhibition of TRPV1 for the treatment of sensitive skin. Exp Dermatol 2010;19:980-6.
8. Kolbe L, Immeyer J, Batzer J, et al. Anti-inflammatory efficacy of licochalcone A: correlation of clinical potency and in vitro effects. Arch Dermatol Res 2006;298:23-30.
9. Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016;74:945-73.
10. Elias PM. Epidermal effects of retinoids: supramolecular observations and clinical implications. J Am Acad Dermatol 1986;15:797-809.
11. Grove G, Zerweck C, Gwazdauskas J. Tolerability and irritation potential of four topical acne regimens in healthy subjects. J Drugs Dermatol 2013;12:644-9.
12. Hayashi N, Kawashima M. Study of the usefulness of moisturizers on adherence of acne patients treated with adapalene. J Dermatol 2014;41:592-7.
13. Gorski J, Proksch E, Baron JM, et al. Dexpanthenol in wound healing after medical and cosmetic interventions (postprocedure wound healing). J Pharm 2020;13.
14. Coderch L, Lopez O, de la Maza A, Parra JL. Ceramides and skin function. Am J Clin Dermatol 2003;4:107-29.
15. Yin S, Luo J, Qian A, et al. Retinoids activate the irritant receptor TRPV1 and produce sensory hypersensitivity. J Clin Invest 2013;123:3941-51.
16. Srour J, Bengel J, Linden T, et al. Efficacy of a skin care cream with TRPV1 inhibitor 4-t-butylcyclohexanol in the topical therapy of perioral dermatitis. J Cosmet Dermatol 2020;19:1409-14.
17. Schmid-Wendtner MH, Korting HC. The PH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol 2006;19:296-302.
18. Schurer N. PH and acne. Curr Probl Dermatol 2018;54:115-22.
19. Prakash C, Bhargava P, Tiwari S, et al. Skin surface pH in acne vulgaris: insights from an observational study and review of the literature. J Clin Aesthet Dermatol 2017;10:33-9.
20. Kistowska M, Gehrke S, Jankovic D, et al. IL-1beta drives inflammatory responses to Propionibacterium acnes in vitro and in vivo. J Invest Dermatol 2014;134:677-85.

Supporting Agencies

This study was funded by Beiersdorf Co., Ltd. (Thailand). The funding body had no role in the design of the study, the collection, analysis and interpretation of data, or the writing of the manuscript.

How to Cite



1.
Triwatcharikorn J, Techamontrikul S, Ngamdumrongkiat N, Rerknimitr P. The efficacy of a bioactive moisturizer in mitigating side effects of acne therapies: a randomized, investigator-blind, split-face trial. Dermatol Reports [Internet]. 2026 Mar. 27 [cited 2026 Jun. 3];. Available from: https://journals.pagepress.net/dr/article/view/10491